Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity.
about
Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysisMechanisms of enzymatic degradation of amyloid Beta microfibrils generating nanofilaments and nanospheres related to cytotoxicity.Somatostatin modulates insulin-degrading-enzyme metabolism: implications for the regulation of microglia activity in ADMetabolism of cryptic peptides derived from neuropeptide FF precursors: the involvement of insulin-degrading enzyme.Structure-activity relationships of imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, dual binders of human insulin-degrading enzyme.Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution.Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in miceThe use of mass spectrometry to study amyloid-β peptides.Functionalized gold nanoparticles for ultrasensitive DNA detection.Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease?Metallostasis and amyloid β-degrading enzymes.Plasmonics for the study of metal ion-protein interactions.Metal complexes and metalloproteases: targeting conformational diseases.Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer's disease.Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.Copper, differently from zinc, affects the conformation, oligomerization state and activity of bradykinin.New Insights into Epigenetic and Pharmacological Regulation of Amyloid-Degrading Enzymes.Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer's disease?Novel Platinum(II) compounds modulate insulin-degrading enzyme activity and induce cell death in neuroblastoma cells.The role of copper(II) in the aggregation of human amylin.Insulin-degrading enzyme (IDE): a novel heat shock-like protein.Multiple allosteric sites are involved in the modulation of insulin-degrading-enzyme activity by somatostatin.Effects of ageing and experimental diabetes on insulin-degrading enzyme expression in male rat tissues.The role of copper(II) and zinc(II) in the degradation of human and murine IAPP by insulin-degrading enzyme.Stimulating the Activity of Amyloid-Beta Degrading Enzymes: A Novel Approach for the Therapeutic Manipulation of Amyloid-Beta Levels.Multiple functions of insulin-degrading enzyme: a metabolic crosslight?Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
P2860
Q27683399-1791910C-2D68-4BDD-9EC1-7D3A5B6429D4Q33536103-63797F2C-6A51-414C-B460-D60BD2880426Q34235168-0B29D53B-6350-4192-A10C-C21D8E7B792EQ34358968-E14A0D19-69B9-4440-8900-DC17E0D2875AQ35075464-0D5F0471-F326-4554-BCCC-25E285FDE6C9Q35694579-2A0599BB-EC55-436F-A98B-6FC23554470FQ36087916-ABDECE1B-3E24-44D4-ABB2-2821434EF5BCQ37866222-8B9913C9-4E48-44B9-820A-E560623AC99CQ37922115-D6FC725F-89B0-413A-B42A-7C29484B4750Q37961852-09327665-A7EC-4243-B9B4-C300840BF5D2Q38029514-8C8D2C9E-0A82-4057-9A46-55142A4FD399Q38050985-0577CC5C-CF75-4FEB-9E2A-7CC0D29E6E2BQ38215608-B20BE3C6-2021-4E6F-A91C-CA1F78588EF2Q38256360-01810FEA-4634-4522-A887-54BB863F272AQ38601445-9C9E5E83-499B-4852-A072-9424C819036AQ38763060-B0F01442-EA4C-4CDA-98D1-40906507B33AQ38834930-3F3E2523-D74E-48F0-8A2B-1D6DE185182EQ38869928-D2DDC958-C0D2-491B-8FF4-943CC670C23FQ38934781-AEAE0900-0863-4FA0-BE39-49BFE930D9A2Q38969830-5052EA97-9292-44FB-9056-6DA307E389B5Q39236799-77C8361B-791B-4D39-8654-1A577E91E9BBQ39436794-11DCA528-3B19-4F43-BF3B-D54AEC28D21FQ41190059-FE84512F-5796-4BF4-AD63-6A356791747AQ42706060-4F65B408-3C5C-43EB-98E5-E5ADE370F5CEQ48547451-AC4AF59D-C6BA-4786-8EFE-EE061471591EQ50932512-A1A82745-351D-49DE-99AD-A4EA8935B3A3Q51608953-132A9DFB-3A76-459B-B6CE-C6C5208FFE33
P2860
Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity.
@ast
Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity.
@en
type
label
Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity.
@ast
Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity.
@en
prefLabel
Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity.
@ast
Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity.
@en
P2093
P1476
Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity.
@en
P2093
Chiara Ciaccio
Daniela Marasco
Giuseppe Spoto
Grazia R Tundo
Magda Gioia
Massimo Coletta
Menotti Ruvo
P304
P356
10.1016/J.JMB.2008.11.025
P407
P577
2008-11-25T00:00:00Z